BR112012033599A2 - novos derivados de tetrahidroquinolina. - Google Patents

novos derivados de tetrahidroquinolina.

Info

Publication number
BR112012033599A2
BR112012033599A2 BR112012033599A BR112012033599A BR112012033599A2 BR 112012033599 A2 BR112012033599 A2 BR 112012033599A2 BR 112012033599 A BR112012033599 A BR 112012033599A BR 112012033599 A BR112012033599 A BR 112012033599A BR 112012033599 A2 BR112012033599 A2 BR 112012033599A2
Authority
BR
Brazil
Prior art keywords
tetrahydroquinoline derivatives
new
new tetrahydroquinoline
derivatives
sym
Prior art date
Application number
BR112012033599A
Other languages
English (en)
Inventor
Hongying Yu
Li Chen
Lichun Feng
Mengwei Huang
Mingwei Zhou
Yongfu Liu
Yun He
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112012033599A2 publication Critical patent/BR112012033599A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)

Abstract

novos derivados de tetrahidroquinolina. um composto da fórmula (i) ou um sal ou éster farmaceuticamente aceitável do mesmo, em que a¹ a a³ e r¹ a r <sym> t~em o significado dado na reivindicação 1, pode ser utilizado como ativador ampk.
BR112012033599A 2010-07-02 2011-06-29 novos derivados de tetrahidroquinolina. BR112012033599A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2010074931 2010-07-02
PCT/EP2011/060864 WO2012001020A1 (en) 2010-07-02 2011-06-29 Novel tetrahydroquinoline derivatives

Publications (1)

Publication Number Publication Date
BR112012033599A2 true BR112012033599A2 (pt) 2016-11-29

Family

ID=44583531

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012033599A BR112012033599A2 (pt) 2010-07-02 2011-06-29 novos derivados de tetrahidroquinolina.

Country Status (10)

Country Link
US (1) US8592594B2 (pt)
EP (1) EP2588458B1 (pt)
JP (1) JP2013534928A (pt)
KR (1) KR20130088843A (pt)
BR (1) BR112012033599A2 (pt)
CA (1) CA2803478A1 (pt)
ES (1) ES2479718T3 (pt)
MX (1) MX2012014647A (pt)
RU (1) RU2013102031A (pt)
WO (1) WO2012001020A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
US9394285B2 (en) 2013-03-15 2016-07-19 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP3089748A4 (en) 2014-01-02 2017-09-27 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
EP4153589A4 (en) 2020-05-19 2024-06-12 Kallyope, Inc. AMPK ACTIVATORS
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
US20240182468A1 (en) * 2022-10-18 2024-06-06 Pfizer Inc. Compounds for the activation of ampk

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3209568B2 (ja) 1991-04-16 2001-09-17 杏林製薬株式会社 新規環状アミノフェニル酢酸誘導体、その製造法及びそれらを有効成分とする免疫応答の修飾剤
US7138412B2 (en) 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
US8344137B2 (en) * 2010-04-14 2013-01-01 Hoffman-La Roche Inc. 3,3-dimethyl tetrahydroquinoline derivatives

Also Published As

Publication number Publication date
EP2588458A1 (en) 2013-05-08
CA2803478A1 (en) 2012-01-05
ES2479718T3 (es) 2014-07-24
RU2013102031A (ru) 2014-08-10
US20120004218A1 (en) 2012-01-05
EP2588458B1 (en) 2014-06-04
KR20130088843A (ko) 2013-08-08
JP2013534928A (ja) 2013-09-09
WO2012001020A1 (en) 2012-01-05
US8592594B2 (en) 2013-11-26
MX2012014647A (es) 2013-02-07

Similar Documents

Publication Publication Date Title
BR112012013847A2 (pt) novos derivados de indolinona ciclopropano
BR112012026338A2 (pt) novos derivados de 3,3-dimetil tetrahidroquinolina
BR112015012919A2 (pt) novos derivados de piridina
RS54873B1 (sr) Policiklična-karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba
BR112015013124A2 (pt) novos derivados de piridina
MX338707B (es) Compuestos heterociclicos activadores de proteina cinasa activada por 5&#39;-amp (ampk) y metodos para emplearlos.
BR112012024199A2 (pt) derivados de n-(imidazopirimidin-7-il)-heteroarilamida e seu uso como inibidores de pde10a
BR112012031343A2 (pt) compostos de heteroarila contendo nitrogênio
BR112015020795A2 (pt) derivados de pirazol novos
BR112013031463A2 (pt) piridina-2-amidas úteis como agonistas de cb2
BR112014032809A2 (pt) melhora de autofagia ou aumento de longevidade pela administração de urolitinas ou precursores das mesmas
BR112015009600A2 (pt) piridina-2-amidas úteis como agonistas cb2
BR112014011055A2 (pt) novos derivados de [1,2,3]triazolo[4,5-d]pirimidina
ME01284B (me) Organska jedinjenja
BR112012026950A2 (pt) composto, e, uso de um composto
EA201270216A1 (ru) Фармацевтический состав
BR112012033599A2 (pt) novos derivados de tetrahidroquinolina.
TN2015000084A1 (fr) Pyridinones bicycliques nouvelles
BR112012030473A2 (pt) pesticidas baseados em derivados pirrolidina espiroheterocíclicos
BR112015009603A2 (pt) novos derivados de pirazina
CO6741154A2 (es) Compuestos de triazolopiridina
BR112014006248A2 (pt) compostos de triazolopiridina como inibidores de pde10a
MY165918A (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
BR112013032758A2 (pt) derivados de n-oxi-pirazolo-triazepino-diona
MA33948B1 (fr) Dérivés d&#39;acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu&#39;agents pharmaceutiques.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]